But opiod/drug makers in the whole world are not going to be easy to stop when there is a proven market demand, are they? Or maybe big law companies already backed big pharma to the nth? -r , mt. shasta)
Overdose deaths are killing more people than homicides and car crashes combined in parts of the U.S., as potent fentanyl and other synthetic opioids flood the heroin market.
https://www.washingtontimes.com/news/2018/feb/12/donald-trump-seeks-billions-opioids-fight/
........................................................................................................................................
3-10-09 The United States Supreme Court upheld the ruling of the Vermont Supreme Court allowing the verdict against Wyeth to stand. The Court completely rejected Wyeth's contention that Congress intended to eliminate the rights of citizens to seek compensation for injuries caused by prescription drugs when it gave the FDA authority to regulate the drug approval process in the Food Drug & Cosmetic Act. Wyeth, supported in its appeal by the rest of the drug industry as well as numerous business-oriented special interest groups, had argued aggressively that FDA approval of a drug and drug labeling should eliminate the ability of consumers to sue for compensation, even in cases where it was clear that the instructions for use and warnings about potential adverse effects were inadequate to protect patients from adverse reactions. http://www.prweb.com/releases/2009/03/prweb2219834.htm
............................................................................................................................
6-21-16 You’re at the pharmacy filling a prescription. The pharmacist asks, “Generic okay?” Without giving it a second thought, you say, “Sure,” (like we all do) and you’re on your way. Not so fast.
If you had taken the brand-name drug, and it turned out that the drug was defective and caused you an injury (like cancer or a stroke) – you could bring a lawsuit against the brand-name drug company and make it pay restitution and reparations. But, if you took the generic form of the drug – you would have absolutely no recourse against the company that made and sold the defective drug. Wait. What? https://www.spanglaw.com/blog/2016/june/generic-drug-manufacturers-still-immune-from-law/
.........................................................................................................................................
9-8-17 Under the deal, which involves the dry-eye drug Restasis, Allergan will pay the tribe $13.75 million. In exchange, the tribe will claim sovereign immunity as grounds to dismiss a patent challenge through a unit of the United States Patent and Trademark Office. The tribe will lease the patents back to Allergan, and will receive $15 million in annual royalties as long as the patents remain valid. The surprising legal move rippled quickly through the pharmaceutical world on Friday, setting off speculation about whether other drug companies would soon follow suit in order to protect their patents from challenges through a patent-review process that the industry despises.
-Dale White, general counsel of the Saint Regis Mohawk Tribe.
If Allergan succeeds in holding onto its patents, “we will probably see multiple branded companies housing their patents with Indian tribes,” Ronny Gal, an analyst for Bernstein, said in a video message to investors on Friday. https://www.nytimes.com/2017/09/08/health/allergan-patent-tribe.html
.................................................................................................................................................
No comments:
Post a Comment